Transcripts

Acumen Pharmaceuticals (ABOS) earnings call transcripts

Earnings call transcripts for Acumen Pharmaceuticals, Inc., with a summary, the guidance given, and what analysts pressed on.

  • Q3 2026 earnings call

    Management framed November’s Phase 2 readout as a pivotal test of oligomer targeting and a potential basis for one confirmatory Phase 3.

    Oct 26, 2026Positive0.55